| RECCE PHARMACEUTICALS LTD |
| Australien |
| Gesundheit |
| AU000000RCE5 / A2ADQM |
| R9Q (Frankfurt) |
| FRA:R9Q, ETR:R9Q, R9Q:GR |
| - |
| https://www.recce.com.au/ |
|
Recce Pharmaceuticals Ltd is a publicly listed biotechnology company specializing in the development of a pioneering class of synthetic anti-infective therapies. Its primary mission is to address the escalating global health threat posed by antibioti..
>Volltext.. |
| 78.8 Mio. EUR |
| 84.49 Mio. EUR |
| - |
| -15.8 Mio. EUR |
| -17.45 Mio. EUR |
| -0.07 EUR |
| 6.18 Mio. EUR |
| 0.21 Mio. EUR |
| -13.7 Mio. EUR |
| 0.05 |
| - |
| -60.35% |
| - |
| - |
| - |
| - |
| RECCE PHARMA, RECCE PHARMACEUTICALS, RECCE PHARMACEUTICAL |
| 02.04.26 |
|